A smaller dose of Moderna’s COVID-19 vaccine is safe and effective in boosting immunity in children aged 6 to 11, the company said. It will submit results to the Food and Drug Administration soon. (CNBC Weekly)

President Biden met with former FDA commissioner Robert Califf last week, the clearest sign that he may nominate Califf for the post. Though the nomination is not final, Califf has emerged in recent weeks as the leading candidate to head the agency. (Politico)

AstraZeneca’s Imfinzi in combination with chemotherapy extended the lives of patients with advanced biliary tract cancer compared to chemotherapy alone, the company said. It added that the results mark “a new era of immunotherapy treatment in this devastating disease.” (Endpoints News)

Researchers at Texas A&M University have developed a new CAR-T cell therapy in which LiCAR-T cells activate in the presence of blue light to fight tumors. The researchers hope the “sci-fi technology” will help make CAR-T cell therapy safer and more effective. (STAT)

Democratic lawmakers pushing for drug pricing reforms received the majority of funds from pharma industry lobbying this year, according to a new Reuters analysis. Groups like PhRMA spent more than $177 million on lobbying and campaign donations in 2021, with 60% of those funds going to Democrats. (Reuters)